Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study.
Akinori HaraKen-Ei SadaTakashi WadaKoichi AmanoHiroaki DobashiTatsuya AtsumiTakahiko SugiharaKouichi HirayamaShogo BannoYohko MurakawaMidori HasegawaKunihiro YamagataYoshihiro ArimuraHirofumi MakinoMasayoshi HarigaiPublished in: Modern rheumatology (2023)
VDI accrual was observed in more than half of patients with AAV during maintenance therapy, and increased VDI scores were associated with oral PSL doses 24 months after initiating remission induction therapy in Japan.